Vistagen Therapeutics (VTGN.MX) Q3 2026 Earnings

14AugConfirmed
Q1 2026
Q3 2026
-8.38
-7.29
-6.2
-5.1

Details

Expected EPS
-6.208139
Actual EPS
-5.102580000000001
Surprise EPS
1.11
Surprise Percent
+17.81%

Description

Vistagen Therapeutics (VTGN.MX) has reported earnings of -5.102580000000001 per share for Q3 2026.

0 Comments

Share your thoughts